tradingkey.logo

Tevogen Bio Sees $1 Bln Revenue In Launch Year For Oncology

ReutersAug 11, 2025 4:31 PM

- Tevogen Bio Holdings Inc TVGN.O:

  • FORECASTS $1 BILLION REVENUE IN LAUNCH YEAR FOR ONCOLOGY PIPELINE

  • PROJECTING CUMULATIVE 5-YEAR ESTIMATE OF BETWEEN $10 BILLION AND $14 BILLION FOR ONCOLOGY PIPELINE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI